Peter C. Goodhand
InvestorPresident (Interim) FACIT Inc at FACIT (Fight Against Cancer Innovation Trust)
About
Experienced health innovation and commercialization executive who is past President of OICR and former President and CEO of the Canadian Cancer Society. He is currently CEO of the Global Alliance for Genomics and Health (GA4GH).
Colleagues at FACIT (Fight Against Cancer Innovation Trust)
Connie Chen
Senior Director, Strategy and Corporate Development at FACIT (Fight Against Cancer Innovation Trust)
David Koehler
Director, Fund Operations at FACIT (Fight Against Cancer Innovation Trust)
David O'Neill
President at FACIT (Fight Against Cancer Innovation Trust)
Elizabeth Douville
Investment Committee Chair at FACIT (Fight Against Cancer Innovation Trust)
Enrico D'Angelo
CFO at Parkwalk Advisors
Francesca Chappell
Chief Finance Officer at BP Marsh & Partners PLC
Kelly Holman
Investment Committee Member at FACIT (Fight Against Cancer Innovation Trust)
Ken Newport
Board Director at FACIT (Fight Against Cancer Innovation Trust)
Frequently asked questions
- Who is Peter C. Goodhand?
- Experienced health innovation and commercialization executive who is past President of OICR and former President and CEO of the Canadian Cancer Society. He is currently CEO of the Global Alliance for Genomics and Health (GA4GH).
- Where does Peter C. Goodhand work?
- Peter C. Goodhand is President (Interim) FACIT Inc at FACIT (Fight Against Cancer Innovation Trust).